Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Louis Gleckel Md currently holds 70,000 shares of ProPhase Labs, Inc. (PRPH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Louis Gleckel Md has been a net buyer of PRPH stock. They have purchased $312.5K and sold $0 worth of shares.
Louis Gleckel Md's most recent insider trade was on Mar 17, 2024, when they sold 70,000 shares at $0.00 per share.
Louis Gleckel Md serves as Executive at ProPhase Labs, Inc. (PRPH). They have executed 20 insider transactions totaling $312.5K over their tenure at the company.
Louis Gleckel Md holds the position of Executive at ProPhase Labs, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 16 years and currently hold a stake valued at $0.
Louis Gleckel Md has shown a buying trading pattern, with $312.5K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Louis Gleckel Md was on Mar 26, 2020, when they purchased $175.0K worth of PRPH shares. This transaction involved 100,000 shares at $1.75 per share.
Louis Gleckel Md currently owns 70,000 shares of ProPhase Labs, Inc. (PRPH), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Louis Gleckel Md's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Louis Gleckel Md has 20 Form 4 filings on record as an insider at ProPhase Labs, Inc..
Set alerts for Louis Gleckel Md and 40,000+ other insiders.